Detalles de la búsqueda
1.
The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor.
Future Oncol;
20(10): 593-601, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593881
2.
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Kidney Int;
100(1): 225-237, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33307104
3.
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab.
Pediatr Nephrol;
36(4): 889-898, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33048203
4.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Kidney Int;
97(6): 1287-1296, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32299680
5.
Corrigendum to "The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2021;100:225-237.
Kidney Int;
104(1): 205, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349053
6.
Corrigendum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2020;97:1287-1296.
Kidney Int;
99(5): 1244, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33892867
7.
Correction to: The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab.
Pediatr Nephrol;
36(4): 1033, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33296010
8.
Erratum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment" Kidney Int. 2020;97:1287-1296.
Kidney Int;
98(6): 1621, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276869
9.
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Clin Gastroenterol Hepatol;
6(2): 242-7, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18187364
10.
Development and validation of a modified performance-oriented mobility assessment tool for assessing mobility in children with hypophosphatasia.
J Pediatr Rehabil Med;
11(3): 187-192, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30223404
11.
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Circulation;
108(4): 399-406, 2003 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-12874182
12.
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
Clin Infect Dis;
40(11): 1601-7, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15889357
13.
Ranking of healthcare programmes based on health outcome, health costs and safe delivery of care in hospital pharmacy practice.
Int J Pharm Pract;
21(1): 46-54, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23301533
14.
Simultaneous detection of As and Se in polyester resin skin phantoms.
Appl Radiat Isot;
68(4-5): 743-5, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-19819714
15.
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).
Am J Cardiol;
102(10): 1285-90, 2008 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18993142
16.
Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon.
Clin Gastroenterol Hepatol;
4(10): 1225-31, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16979948
17.
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.
Antimicrob Agents Chemother;
50(3): 862-7, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16495243
18.
A Bayesian approach to case-control studies with errors in covariables.
Biostatistics;
3(2): 229-43, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12933615
19.
The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
J Hepatol;
40(3): 484-90, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15123364
Resultados
1 -
19
de 19
1
Próxima >
>>